|
References  |
|
|
| *references marked with an asterisk below are user-added references |
|
U.S. References |
|
|
| Add a new US reference: |
| | Reference | Relevancy | Comments | Reference | Relevancy | Comments | 3288137
|      Your vote accepted [0 after 0 votes] | | 3699956
|      Your vote accepted [0 after 0 votes] | | 4710174 Moden 604/175 Dec,1987 |      Your vote accepted [0 after 0 votes] | | 4710167 Lazorthes 604/288.02 Dec,1987 |      Your vote accepted [0 after 0 votes] | | 4704103 Stober 604/175 Nov,1987 |      Your vote accepted [0 after 0 votes] | | 4695273 Brown 604/173 Sep,1987 |      Your vote accepted [0 after 0 votes] | | 4692146 Hilger 604/288.01 Sep,1987 |      Your vote accepted [0 after 0 votes] | | 4673394 Fenton, Jr. 604/175 Jun,1987 |      Your vote accepted [0 after 0 votes] | | 4645495 Vaillancourt 604/180 Feb,1987 |      Your vote accepted [0 after 0 votes] | | 4634443 Haber 600/31 Jan,1987 |      Your vote accepted [0 after 0 votes] | | 4581020 Mittleman 604/175 Apr,1986 |      Your vote accepted [0 after 0 votes] | | 4578063 Inman 604/175 Mar,1986 |      Your vote accepted [0 after 0 votes] | | 4543088 Bootman 604/288.02 Sep,1985 |      Your vote accepted [0 after 0 votes] | | 4490137 Moukheibir 604/28 Dec,1984 |      Your vote accepted [0 after 0 votes] | | 4464178 Dalton 604/174 Aug,1984 |      Your vote accepted [0 after 0 votes] | | 4459318 Hyans 427/551 Jul,1984 |      Your vote accepted [0 after 0 votes] | | 4230109 Geiss 604/533 Oct,1980 |      Your vote accepted [0 after 0 votes] | | 4190040 Schulte 128/899 Feb,1980 |      Your vote accepted [0 after 0 votes] | | 3752162 Newash 604/175 Aug,1973 |      Your vote accepted [0 after 0 votes] | | 4439188 Dennehey 604/534 Dec,1969 |      Your vote accepted [0 after 0 votes] | | |
|
|
|
|
U.S. References |
|
|
Foreign References |
|
|
|
|
|
|
Foreign References |
|
|
Other References |
|
|
|
|
|
|
Other References |
|
|
|
|
|
References  |
|
|
Description  |
|
|
BACKGROUND OF THE INVENTION
This invention relates to an implantable device and in particular, to a
vascular access device that is implanted subcutaneously.
Within the prior art, a variety of implantable access devices are known.
Typical is the commercially available INFUSAID Infuse-A-Port.TM.. These
techniques of providing access via a various implantable device include
percutaneous catheters, implantable ports having access to a port at a
perpendicular angle to the skin and direct access with a needle. Thus, in
the case of the commercially available Infuse-A-Port.TM., a base having an
inlet located under the skin having an access outlet perpendicular to the
skin line. The catheter thus extends at a right angle to the direction of
needle access to the port's inlet.
Materials which are used in these devices generally include various
plastics such as PVC, teflon, polyethylene, polypropylene, polyurethane,
polycarbonate, polyethersulfone, polysulfone, polyolefin, nylon and the
like. Additionally, silicone rubber, stainless steel and titanium are
used.
A hallmark characteristic of all previous techniques of access utilizing
implantable ports is a requirement that a needle be placed into the port
septum at a 90.degree. angle to the outlet catheter. This is acceptable
for bolus injections or infusions over brief periods of time. However, for
longer infusions or for continuous infusions with these ports, a right
angle needle is required to allow for the hub of the needle to be parallel
with the skin. This is required to permit anchoring of the needle to the
body during infusions.
Another disadvantage with such prior art devices is that they require minor
but, a distinct surgical procedure for implantation. That is, the size of
the base is such that a significant incision is required for implantation.
Moreover, given the size of the base, implantation is required in specific
portions of the body, for example, the chest and stomach area that can
physically support and house the port without protuberances or discomfort
to the patient.
Given these deficiencies of prior art devices, it is an object of this
invention to define an implantable access device for humans having a low
profile capable of implantation in a variety of bodily locations, which
provides access to multiple body sites.
Yet another object of this invention is to define a low, acute angle
implantable port which provides access to multiple body sites for research
purposes in animals.
Yet another object of this invention is to provide an acute angle
implantable device providing access to multiple body sites in small
patients, such as infants, neonates and children.
A further object of this device is to provide for an implantable port which
has a reduced size such that implantation can be carried out minimizing
both the surgical procedure time and size of the incision.
These and other objects of this invention are achieved by means of an acute
angle port having a port body holding a self-sealing septum. The port body
has grooves, wings, or flaps which allow for suturing the port to
subcutaneous tissue. The self-sealing septum in accordance with this
invention has the ability to be connected to various catheters such that
when coupled, the port provides direct facile access to the catheter. This
direct access to the catheter allows for catheter tip placement or for the
management of blockages in the catheter. Such is extremely difficult in
the context of ports which are disposed at right angles to the catheter
output.
These and other objects of this invention are set forth herein by reference
to the attached drawings and the descriptions of the preferred embodiments
which follows.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic perspective view of a first embodiment of an
implantable port in accordance with this invention;
FIG. 2 is a schematic illustration showing the placement of the implantable
port of this invention subcutaneously with the catheter extended into a
blood vessel;
FIG. 3 is a schematic cut-away view of a second embodiment of this
invention;
FIG. 4 is a perspective view of the embodiment of FIG. 3 utilizing a
separately molded tie-down element;
FIG. 5 is an end view of the tie-down element of FIG. 4;
FIG. 6 is a schematic cut-away side view of a third embodiment of this
invention; and
FIG. 7 is a schematic cut-away side view of a fourth embodiment of this
invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring now to FIG. 1, a first embodiment of the implantable port of this
invention is illustrated. The port comprises a body member 10 having a
self-sealing septum 12 and an outlet connector 14 to which a suitable
catheter is mounted. As illustrated in FIG. 1, the port has a generally
flat base area 16 with an inclined face 18 into which the septum is
placed. The septum provides a small diameter target, typically 0.15-0.20
inches. The overall length of the device from the front face to the tip of
the connector is in the range of one inch. The overall height of the
device from the flat base 16 to the tapered top portion is at a maximum
approximately 0.38 inches. The port and the connector is manufactured from
a bicompatible material. Materials of choice for the port are silicone
rubber and various plastics such as PVC, teflon, polyethylene,
polypropylene, polyurethane, polycarbonate, polyethersulfone, polysulfone,
polyolefin, nylon, and the like. The connecter is preferably a metallic
member made of stainless steel or titanium. The entire device can be made
of one piece, for example a suitable metal.
As illustrated in FIG. 1, the front face 18 is inclined so that access to
the self-sealing septum 12 is axially aligned with the connecter 14. This
is in contrast to prior art systems wherein normal access to the septum
would be disposed at a right angle, that is perpendicular to the outlet
connector to the catheter.
Given the low profile of the device, implantation in areas with limited
subcutaneous tissue such as forearms, scalp and neck area, infants and
children and their appendages is possible.
Referring now to FIG. 2, the device of FIG. 1 including the catheter is
shown implanted. Specifically, the port 10 has coupled to it a catheter 20
of suitable length. The catheter is force-fitted onto the connecter 14
having its free end lanced into a suitable blood vessel 22. The catheter
made from a biocompatible material such as silicone rubber or polyurethane
and depending on the application may have a radiopaque material added. The
device is implanted under the skin 24 by making a small localized incision
26. The incision is shallow and does not involve incursion into underlying
muscle tissue 28. Given the low profile of the device, a small protrusion
30 in the skin is present but such is not obtrusive or acts in any way as
an impediment to normal functioning at the implantation site.
Access to the device 10 is by means of a needle 32. As can be seen from
FIG. 2. The needle penetrates the skin at the protrusion 30 directly into
the target or port zone 12 and is in line with the outlet 14. A major
advantage of this system is that given the in-line nature of the septum,
outlet and catheter access to the catheter tip for management of blockages
is possible. This also allows the use of straight needles as illustrated
in FIG. 2 for access to the port since entry is generally parallel to the
skin line. Moreover, if it is necessary to pass a guide wire through the
port and into the catheter, such can be done without making any
significant bends. The ability to pass a guide wire or other appropriate
device into the catheter after implantation provides a significant
advantage in terms of clearing the catheter or importantly, initially
placing the catheter tip at an appropriate location within the body. Such
is extremely difficult in prior art right angle systems.
As can be appreciated from FIG. 2, the use of a straight needle provides a
material advantage over prior techniques. Additionally, if the needle is
required to be taped down then, it is a simple matter of affixing the
needle when in contact with the septum to the skin yet not substantially
immobilize the patient. Thus, for example, if the port 10 is implanted in
an arm the needle can simply be taped or strapped in place thereby
anchoring the needle to the body during infusion or injections requiring a
period of time.
FIG. 3 illustrates a second embodiment of an in-line port in accordance
with this invention. As illustrated in FIG. 3, the port is generally
circular and comprises the body member 30 having an opening 32. A
self-sealing septum 34 is placed into the body 30 to close off the opening
32 and provide a suitable target. The port has a hollow portion 36
generally axially in line with the self-sealing septum 34. The hollow
portion serving as a reservoir terminates into a zone which is tapped,
that is area 38 to allow for the catheter connection. The overall length
of the device is in the range of 0.75-1.0 inches. The maximum diameter is
in the range of 0.4 inches. The exposed area, that is opening 32 is in the
range of 0.25 inches. As in the case of the first embodiment a variety of
materials may be used, such as polysulfone.
The device of FIG. 3 has two annular shoulders 40 and 42. These shoulders
provide zones for holding a tie-down element (not illustrated) around the
device.
Referring now to FIGS. 4 and 5, a perspective vein of the port illustrated
in FIG. 3 is depicted. The numeral is used to identify the same aspects of
the embodiment of FIG. 3 are used in FIGS. 4 and 5. Additionally, FIG. 4
illustrates the connecter 44 for the catheter coupled to the outlet
portion of the port, that is, screwed into the zone 38 and having a series
of annular barbs or serrations upon which the catheter is fixed.
As illustrated in FIG. 5 the tie-down comprises a separate element which is
a separately molded material. Specifically, the tie-down 50 comprises a
body portion 52 inclined to the horizontal relative to a base portion 54.
Through an opening 56, the device 30 is inserted such that as illustrated
in FIG. 4 the rear portion of the device at shoulder 30 butts against the
rear portion of the tie-down while the front shoulder 40 butts against the
inclined front wall. Consequently, when snapped into position the tie-down
inclines the port and provides a pair of extending "wings" for purposes of
suturing the device into place. Various techniques of suturing the wings
56, 58 may be used. As illustrated in FIG. 4, a series of holes 60 can
allow for sutures to be stitched through and around each of the wings.
Alternatively, a zone of exposed dacron fabirc 62 may be used to provide a
confined anchoring area on each of the wing surfaces.
Referring now to FIG. 6, a third preferred embodiment of this invention is
illustrated. The embodiment of FIG. 6 departs from that illustrated in
FIG. 3 in that the device while retaining its generally truncated conical
form eliminates the shoulder zones 40 and 42. In its place, two annular
rings 60 and 62 are employed. These provide two suture hold down
locations. Another variation is that the hollow area 64 in the embodiment
of FIG. 6 is generally rectangular and has a truncated zone 66 coupling a
straight in-line portion 68 to the hollow area 64. This serves as a guide
for the needle, it being understood that the needle would generally
terminate in the zone 64 providing direct fluid access to the catheter.
The barbed connector which would be screwed into the device and the
threaded portion 38.
Referring now to FIG. 7, a fourth embodiment of this invention is depicted.
In FIG. 7, the device comprises a generally squat body portion 70 having a
self-sealing septum 72 embedded therein. The septum 72 is inclined
relative to the horizontal flat bottom portion of the device and has a
cavity portion 74 defined within the body 70. An outlet hollow port 76 is
in fluid communication with an external connector piece 78. The connector
piece is force-fitted or the like into the body portion 70 and serves as
the connector between the port and the catheter. The body portion may be
made of polysulfone or the like and, as illustrated in FIG. 7 has a very
low profile. Needle access is provided at a shallow, acute angle to the
self-sealing septum 72. The device is anchored in place by through-holes,
wings or the like which are not illustrated.
It is apparent that while multiple embodiments of this invention have been
illustrated, various other modifications can be made without departing
from the essential scope of the invention. A key aspect is the geometry of
the device so that straight needles can be used with the device implanted
at a very shallow implantation site within an arm, the neck area or the
like. Such is considered a material advantage over prior art systems which
must be implanted in the torso given their overall size and geometry.
* * * * *
|
|
|
|
|
Description  |
|